Anti-tuberculosis vaccine BCG10

Anti-tuberculosis vaccine BCG10
Product Description

BCG 10 Anti-Tuberculosis Vaccine is used for protective vaccinations against tuberculosis. Catch-up (supplementary) vaccinations in subjects unvaccinated after birth should be performed as early as possible, no later than at 15 years of age. In case of BCG immunisation booster vaccine doses are not recommended.  One dose (0.1 ml) contains 50 micrograms of semi-dry mass of BCG bacilli which corresponds to amount from 150 000 to 600 000 of live BCG bacilli (Bacillus Calmette-Guerin), the Brazilian Moreau substrain.   One ampoule or vial with the powder contains: 0.5 mg (from 1.5 mln to 6 mln) of live BCG bacilli (Bacillus Calmette-Guerin), the Brazilian Moreau substrain.

Synthaverse S.A.

  • PL
  • 2023
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Specifications
  • Selling Points
    Immune Health

Synthaverse S.A.

  • PL
  • 2023
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical

More Products from Synthaverse S.A. (2)

  • Distreptaza

    Product Distreptaza

    Rectal suppositories indicated for:

    1) Supportive treatment of pelvic inflammatory disease (PID) –  inflammatory diseases of the ovaries, fallopian tubes and endometrium,
    2) Adhesions after abdominal surgical procedures,
    3) Acute haemorrhoidal disease and chronic haemorr...
  • Onko BCG 100

    Product Onko BCG 100

    BCG for immunotherapy.
    The product is intended for treatment of superficial, epithelial non-invasive urothelial carcinomas (carcinoma urotheliale Ta, Tis, T1)

    1 ampoule or 1 vial with the powder contains:
    Live attenuated bacilli Bacillus Calmette-Guerin, Brazilian BCG Moreau substrain ...